Fusion protein and its applicaton in preparing medicine for treating tumor and/or viral infection
US12162947B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2021 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Oct 1, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a fusion protein and methods thereof for preparing a pharmaceutical composition comprising the fusion protein and for methods for treating tumors and/or viral infections using said fusion proteins and compositions, wherein the fusion protein comprises an antibody or antigen-binding fragment thereof that specifically binds to human OX40 and a human interferon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.